gms | German Medical Science

67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Koreanischen Gesellschaft für Neurochirurgie (KNS)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

12. - 15. Juni 2016, Frankfurt am Main

Perioperative administration of corticosteroids in patients with primary CNS B-Cell-Lymphoma

Meeting Abstract

  • Florian Geßler - Klinik für Neurochirurgie, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
  • Peter Baumgarten - Klinik für Neurochirurgie, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany; Neurologisches Institut, Edinger Institut, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
  • Johanna Quick - Klinik für Neurochirurgie, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
  • Gerhard Marquardt - Klinik für Neurochirurgie, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
  • Volker Seifert - Klinik für Neurochirurgie, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
  • Lutz Weise - Klinik für Neurochirurgie, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany

Deutsche Gesellschaft für Neurochirurgie. 67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 1. Joint Meeting mit der Koreanischen Gesellschaft für Neurochirurgie (KNS). Frankfurt am Main, 12.-15.06.2016. Düsseldorf: German Medical Science GMS Publishing House; 2016. DocMO.10.05

doi: 10.3205/16dgnc044, urn:nbn:de:0183-16dgnc0448

Veröffentlicht: 8. Juni 2016

© 2016 Geßler et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Treatment of primary central nervous system lymphoma (PCNSL) is still a matter of intense research and clinical studies. Although often included in the treatment regimens (e.g. R-CHOP), the administration of corticosteroids (CS) prior to chemotherapy remains controversial due to a possible “priming” of tumor cells resulting in reduced response to anti-CD20 therapies.

Method: In our department, a total of 54 patients were diagnosed with PCNSL after stereotactic biopsy from 2009 to 2013. Perioperative corticosteroid administration, patient and tumor characteristics, surgical complications, postoperative treatment, histopathological markers, clinical course and outcome were included in the database.

Results: Of the 54 patients, 33 patients (61.1%) received perioperative corticosteroid medication. No differences in both treatment groups were observed with regard to age, gender, time of follow-up, rate of remission or partial remission, CD20 expression, CD45 expression, CD3 expression, tumor staging as assessed by CSF pathology and imaging/bone marrow pathology. No significant differences in imaging parameters as deep-site involvement or multifocal involvement were observed. No significant differences regarding intraoperative complications such as bleeding or postoperative neurological worsening were observed. The histopathological diagnosis of B-Cell PCNSL was obtained in all cases. No significant differences regarding progression-free survival (PFS) (p=0.86) and overall survival (OS) (p=0.79) were observed between both treatment groups. Of the investigated parameters only higher age was associated with reduced PFS (HR=1.36; p<0.05) and OS (HR=1.44; p<0.05).

Conclusions: Our data suggest that perioperative administration of corticosteroids is not associated with altered rates of response to therapy as observed by remission rates. Moreover, no significant differences between PFS and OS were observed in both treatment groups. Hence, administration of perioperative corticosteroids after completion of biopsy might be performed if deemed necessary.